E-submission
Search
- Page Path
- HOME > Search
Brief Case Report
- EGFR-mutated pulmonary adenocarcinoma with concurrent PIK3CA mutation, and with acquired RET fusion and EGFR T790M mutation after afatinib therapy
- Minhye Kim, Ji Min Na, Gyeong-Won Lee, Seung Jun Lee, Jong Duk Kim, Jung Wook Yang
- J Pathol Transl Med. 2021;55(1):79-82. Published online December 3, 2020
- DOI: https://doi.org/10.4132/jptm.2020.11.02
- 3,216 View
- 109 Download
- 3 Web of Science
- 2 Crossref
-
PDF -
Citations
Citations to this article as recorded by
- Case report: First evidence of impressive efficacy of modulated dose selpercatinib in a young Caucasian with ANK3-RET fusion-positive NSCLC
Elisa De Carlo, Elisa Bertoli, Monica Schiappacassi, Brigida Stanzione, Alessandro Del Conte, Roberto Doliana, Michele Spina, Alessandra Bearz
Frontiers in Oncology.2024;[Epub] CrossRef - RET Proto-Oncogene—Not Such an Obvious Starting Point in Cancer Therapy
Tomasz Kucharczyk, Paweł Krawczyk, Dariusz M. Kowalski, Adam Płużański, Tomasz Kubiatowski, Ewa Kalinka
Cancers.2022; 14(21): 5298. CrossRef
- Case report: First evidence of impressive efficacy of modulated dose selpercatinib in a young Caucasian with ANK3-RET fusion-positive NSCLC
First
Prev
